GMP IPO Watch logo GMP IPO Watch
Equity Scheme - Sectoral/ Thematic

Mirae Asset Healthcare Fund

Direct Plan · Growth · Mirae Asset Mutual Fund

Risk: Very High Risk
52W Low ₹40.46 29 Jan 2026 52W High ₹55.49 9 Nov 2026
₹54.9490 NAV as of 16 Nov 2026 -0.55% day change
ISININF769K01ED6
Scheme Code143783
StructureOpen Ended Schemes
Fund HouseMirae Asset Investment Managers (India) Pvt. Ltd
AUM (avg. July - September 2026)₹901.67 Cr
Expense Ratio (as of 15 Nov 2026)0.59%
Min. Investment₹5,000
Inception Date11 Jun 2018
BenchmarkNifty 500 Healthcare TRI (Total Return Index)
Portfolio Turnover32.27%
NFO Period27 Jan 2026 – 06 Feb 2026

Returns

1Y +26.19%
3Y +23.91%
5Y +17.51%
7Y +26.27%
Since Inception +22.48%

Annualised (CAGR) returns for periods over a year.

Want to invest in this fund?

Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.

Open Free Account

Rank in Category

PeriodThis FundCategory Avg.Rank
1W -0.97% +0.82% 247 of 255
1M +10.50% +4.89% 5 of 255
3M +6.76% -0.60% 2 of 253
6M +15.40% +7.00% 30 of 251
YTD +28.53% +4.66% 5 of 255
1Y +26.19% +4.25% 4 of 232
2Y +16.05% +5.40% 10 of 188
3Y +23.91% +12.36% 4 of 142
5Y +17.51% +10.32% 11 of 103
7Y +26.27% +15.01% 1 of 85
INCEPTION +22.48% — —

Ranked among: Equity Scheme - Sectoral/ Thematic.

Rolling Returns

PeriodAverageBestWorstPositive PeriodsConsistency
3M +5.49% +49.76% -13.58% 69% 28%
6M +11.53% +78.01% -15.43% 72% 31%
1Y +24.96% +93.05% -11.12% 82% 38%
2Y +25.33% +59.12% -0.22% 100% 47%
3Y +23.79% +35.78% +14.26% 100% 48%
5Y +22.92% +34.26% +14.59% 100% 48%
7Y +23.59% +26.49% +21.11% 100% 49%

Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.

NAV History

AUM Trend (₹ Cr, quarterly average)

Expense Ratio Trend

Portfolio · Oct 2026

Asset Allocation

  • Equity99.89%
  • Debt0.00%
  • Cash0.11%
  • Other0.00%

Market Cap Split

  • Large Cap35.16%
  • Mid Cap41.69%
  • Small Cap23.04%
  • Others0.11%

Fundamentals

FundCategory
P/E42.6842.27
P/B6.035.99
Price / Sales6.245.83
Price / Cash Flow32.1830.84
Dividend Yield (%)0.470.59
Holdings29
Top 5 Stocks38.88%
Top 10 Stocks59.80%
Top 3 Sectors98.20%

Holdings · Oct 2026

HoldingSectorWeightChange (1M)
Sun Pharmaceutical Pharmaceuticals & Biotechnology 10.32% +0.17%
Divis Laboratories Pharmaceuticals & Biotechnology 9.97% +0.18%
Torrent Pharmaceuticals Pharmaceuticals & Biotechnology 6.41% -0.39%
Laurus Labs Pharmaceuticals & Biotechnology 6.37% +0.86%
Apollo Hospitals Equity 5.81% +0.19%
Dr Reddys Laboratories Pharmaceuticals & Biotechnology 5.45% +0.61%
Glenmark Pharmaceuticals Pharmaceuticals & Biotechnology 4.61% -0.17%
Aurobindo Pharma Pharmaceuticals & Biotechnology 3.73% -0.05%
Alkem Laboratories Pharmaceuticals & Biotechnology 3.65% -0.11%
Krishna Institute of Medical Sciences Equity 3.48% +0.09%
IPCA Laboratories Pharmaceuticals & Biotechnology 3.33% -0.06%
Sai Life Sciences Pharmaceuticals & Biotechnology 3.23% +0.00%
Aster DM Quality Care Equity 3.19% -0.13%
Dr. Lal Path Labs Equity 3.05% +0.15%
Onesource Specialty Pharma Pharmaceuticals & Biotechnology 3.04% +0.03%
View all 31 holdings
Fortis Healthcare Equity 2.87% -0.07%
Gland Pharma Pharmaceuticals & Biotechnology 2.82% +0.13%
Cipla Pharmaceuticals & Biotechnology 2.65% +0.02%
Eris Lifesciences Pharmaceuticals & Biotechnology 2.27% -0.12%
Lupin Pharmaceuticals & Biotechnology 2.20% -0.07%
Mankind Pharma Pharmaceuticals & Biotechnology 2.19% -0.05%
Max Healthcare Institute Equity 2.13% -0.22%
Biocon Pharmaceuticals & Biotechnology 1.97% -0.03%
Molbio Diagnostics Equity 1.69% -0.08%
Symbiotec Pharmalab Pharmaceuticals & Biotechnology 1.66% +0.06%
Neogen Chemicals Chemicals & Petrochemicals 1.41% -0.09%
Deepak Nitrite Chemicals & Petrochemicals 0.39% -0.01%
TREPS Reverse Repo / TREPS 0.23% —
Mirae Asset Liquid Fund-Direct Plan-Growth Others 0.01% +0.00%
Narayana Hrudayalaya Equity 0.00% +0.00%
Net Receivables / (Payables) Net Current Assets -0.12% —

Sector Allocation · Oct 2026

Risk Metrics

Standard Deviation

PeriodFundCategory
1Y 14.12 16.52 Low Volatility
3Y 14.36 16.17 Low Volatility
5Y 13.88 15.67 Low Volatility
What is this?

Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.

Sharpe Ratio

PeriodFundCategory
1Y 0.97 -0.32 Above Average
3Y 1.11 -0.45 Above Average
5Y 0.72 0.29 Above Average
What is this?

Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.66% (published 2026-11-09).

Sortino Ratio

PeriodFundCategory
1Y 2.75 0.47 Above Average
3Y 2.34 1.15 Above Average
5Y 1.83 1.00 Above Average
What is this?

Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.

Beta

PeriodFundCategory
1Y 0.92 0.96 Good Risk Adjusted Returns
3Y 0.97 0.96 Poor Risk Adjusted Returns
5Y 0.97 0.95 Poor Risk Adjusted Returns
What is this?

This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.

Compare With Peers

Scheme 1Y3Y5YSince Inception
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
+47.99% +39.68% — +20.63%
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
+30.16% +30.90% — +31.59%
Kotak Healthcare Fund
Regular Plan · IDCW Option
+30.07% — — +21.71%
SBI Automotive Opportunities Fund
Direct Plan · IDCW
+26.08% — — +12.79%
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
+25.74% — — +14.17%
Edelweiss Recently Listed IPO Fund
Regular Plan · Growth
+24.72% +16.31% +9.45% +14.99%
SBI HEALTHCARE OPPORTUNITIES FUND
Regular Plan · IDCW
+23.72% +23.59% +19.01% +12.39%
WhiteOak Capital Pharma and Healthcare Fund
Regular Plan · Growth Option
+22.99% — — +21.91%
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
+21.93% +19.54% +12.36% +15.87%
Bajaj Finserv Healthcare Fund
Regular Plan · Growth
+20.99% — — +10.06%

More From Mirae Asset Investment Managers (India) Pvt. Ltd

Scheme 1Y3Y5YSince Inception
Mirae Asset NYSE FANG + ETF Fund of Fund
Direct Plan · Growth
+36.47% +54.16% +32.24% +34.16%
Mirae Asset S&P 500 Top 50 ETF Fund of Fund
Direct Plan · Growth
+35.84% +43.10% +26.24% +27.02%
Mirae Asset Global X Artificial Intelligence & Technology ETF Fund of Fund
Direct Plan · Growth
+24.08% +32.80% — +32.54%
Mirae Asset Nifty Metal ETF
+19.43% — — +11.00%
Mirae Asset NYSE FANG+ ETF
+12.53% +34.40% +22.14% +24.07%
Mirae Asset Nifty PSU Bank ETF
+11.26% — — +17.42%
Mirae Asset S&P 500 Top 50 ETF
+10.78% +24.72% +16.54% +18.09%
Mirae Asset Multi Asset Allocation Fund
Direct Plan · Growth
+7.79% — — +13.60%
Mirae Asset Small Cap Fund
Direct Plan · IDCW
+7.03% — — +14.15%
Mirae Asset Gold ETF
+7.01% +29.35% — +25.16%

About This Scheme

Investment Objective

The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty 500 Healthcare Total Return Index, subject to tracking error. There is no assurance that the investment objective of the scheme will be achieved.

Stated Asset Allocation

Securities included in Nifty 500 Healthcare Index- 95 to 100% ; Money market instruments* including Tri Party REPO/ debt securities, Instruments and/or units of debt/liquid schemes of domestic Mutual Funds- 0 to 5 %

Exit Load

NIL

Fund Managers

Mr. Vishal Singh & Mr. Sudip Shere

Mr. Vishal Singh (Primary) & Mr. Sudip Shere (Primary)

Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.

Market Open · Closes 3:30 PM
NSE BSE NFO BFO CDS BCD MCX NSCOM